ArticleEuropean radiology2026
Prognostic value of baseline PSMA PET/CT for survival in synchronous metastatic hormone-sensitive prostate cancer: towards redefining low- and high-volume disease.
Fleur Kleiburg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.